[go: up one dir, main page]

SE420566B - Diagnostiseringsmedel for intravaskuler administrering - Google Patents

Diagnostiseringsmedel for intravaskuler administrering

Info

Publication number
SE420566B
SE420566B SE7407461A SE7407461A SE420566B SE 420566 B SE420566 B SE 420566B SE 7407461 A SE7407461 A SE 7407461A SE 7407461 A SE7407461 A SE 7407461A SE 420566 B SE420566 B SE 420566B
Authority
SE
Sweden
Prior art keywords
june
blood plasma
water
intravascularly
intravascular administration
Prior art date
Application number
SE7407461A
Other languages
English (en)
Other versions
SE7407461L (sv
Inventor
U S E Rothman
B J Lindberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE7407461A priority Critical patent/SE420566B/sv
Priority to AU81646/75A priority patent/AU8164675A/en
Priority to DE19752524278 priority patent/DE2524278A1/de
Priority to GB24287/75A priority patent/GB1518813A/en
Priority to CA228,779A priority patent/CA1039274A/en
Priority to FR7517632A priority patent/FR2273516A1/fr
Priority to JP50067731A priority patent/JPS517113A/ja
Priority to NL7506743A priority patent/NL7506743A/xx
Publication of SE7407461L publication Critical patent/SE7407461L/sv
Publication of SE420566B publication Critical patent/SE420566B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE7407461A 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering SE420566B (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering
AU81646/75A AU8164675A (en) 1974-06-06 1975-05-29 A diagnostic agent
DE19752524278 DE2524278A1 (de) 1974-06-06 1975-05-31 Diagnostisches mittel, hilfsmittel zu dessen herstellung sowie diagnoseverfahren
GB24287/75A GB1518813A (en) 1974-06-06 1975-06-05 Diagnostic agent
CA228,779A CA1039274A (en) 1974-06-06 1975-06-05 Diagnostic agent
FR7517632A FR2273516A1 (fr) 1974-06-06 1975-06-05 Agent de diagnostic pour l'administration intravasculaire
JP50067731A JPS517113A (sv) 1974-06-06 1975-06-06
NL7506743A NL7506743A (nl) 1974-06-06 1975-06-06 Diagnosticum.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Publications (2)

Publication Number Publication Date
SE7407461L SE7407461L (sv) 1975-12-08
SE420566B true SE420566B (sv) 1981-10-19

Family

ID=20321348

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Country Status (8)

Country Link
JP (1) JPS517113A (sv)
AU (1) AU8164675A (sv)
CA (1) CA1039274A (sv)
DE (1) DE2524278A1 (sv)
FR (1) FR2273516A1 (sv)
GB (1) GB1518813A (sv)
NL (1) NL7506743A (sv)
SE (1) SE420566B (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501726A (en) * 1981-11-12 1985-02-26 Schroeder Ulf Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Also Published As

Publication number Publication date
FR2273516A1 (fr) 1976-01-02
SE7407461L (sv) 1975-12-08
JPS517113A (sv) 1976-01-21
AU8164675A (en) 1976-12-02
NL7506743A (nl) 1975-12-09
DE2524278A1 (de) 1975-12-18
FR2273516B1 (sv) 1979-01-05
GB1518813A (en) 1978-07-26
CA1039274A (en) 1978-09-26

Similar Documents

Publication Publication Date Title
EP0787017B2 (en) Diagnostic preparation for detection of helicobacter pylori
CA1165686A (en) Radioactive diagnostic agent and non-radioactive carrier therefor
US4071613A (en) Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation
SE420566B (sv) Diagnostiseringsmedel for intravaskuler administrering
Whitby Enzymic formation of a new riboflavin derivative
Ekenved ABSORPTION FROM DIFFERENT TYPES OF IRON TABLETS‐CORRELATION BETWEEN SERUM IRON INCREASE AND TOTAL ABSORPTION OF IRON
EP0280135B1 (de) Protein C-Inhibitor (PCI) als Pharmazeutikum und Diagnostikum, Verfahren zu Herstellung eines solchen Pharmazeutikums oder Diagnostikums sowie ein Mittel enthaltend PCI
EP0063946A1 (en) Diagnosis of kidney function
Rajewsky Researches in the problem of radium poisoning and the tolerance dose of radium
DE69001000T2 (de) Radioaktives diagnosemittel.
Esquerre et al. Kinetics of technetium-labeled heparin in thromboembolism: Preliminary Report
Ainsworth An ultrastructural method for the use of polyvinylpyrrolidone and dextrans as electron opaque tracers.
Caputo et al. Letterer-Siwe disease in an octogenarian
Balaban et al. Effect of the radiolabel mediator tropolone on lymphocyte structure and function
Turan et al. Evaluation of 99m Tc-citrate, 67 Gacitrate and 99m Tc (V) dimercaptosuccinic acid for the scintigraphic visualization of acute appendicitis
Rosenau Dangers in the use of certain halogenated phthaleins as functional tests
JPS5842846B2 (ja) 肝臓および骨髄走査用テクネチウム−９９ｍ標識放射線診断剤とその製造法
JPS63170400A (ja) 放射性医薬品とその調製用高分子化合物
GB2055044A (en) Glucuronidase activity and/or phdependent pharmaceuticals and their methods of production and use for selective treatment of diseases
JPS60126231A (ja) 放射性診断剤
Perin et al. Evaluation of possible interference of anti-inflammatory drugs upon scintigraphic imaging with macrophage targeting 99mTc-J001X: Effects of methylprednisolone, dexamethasone, indomethacin and methotrexate
Hurwitz et al. Distribution of 67Ga Following Intravenous Administration: Effects of Disodium Edetate Therapy
Slosman et al. Cerebral Spect Imaging: Advances in Radio Pharmaceuticals and Quantitative Analysis
King et al. Laboratory methods for screening possible inhibitors of dental caries
Chatterjee Debnath et al. Technetium-99m cysteine; a novel radiopharmaceutical for detection of experimental myocardial infarction in rats